Masculinizing chest wall gender-affirming surgery: Clinical outcomes of 73 subcutaneous mastectomies using the double-incision and semicircular incision techniques
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2023
DOI: 10.1016/j.bjps.2023.07.020 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2023. Verfasst von Alessandro Innocenti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Plastic and Reconstructive Microsurgery, Careggi University Hospital, Florence, Italy. Electronic address: a.innocenti@unifi.it. Hauptthemen laut MEDLINE: Gender-Affirming Surgery, Mastectomy, Subcutaneous, Thoracic Wall, Transsexualism. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Plastic and Reconstructive Microsurgery, Careggi University Hospital, Florence, Italy. Electronic address: a.innocenti@unifi.it.
- Plastic and Reconstructive Microsurgery, Careggi University Hospital, Florence, Italy.
Zitieren
APA
Innocenti, A., & Biban, G. (2023). Masculinizing chest wall gender-affirming surgery: Clinical outcomes of 73 subcutaneous mastectomies using the double-incision and semicircular incision techniques. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2023.07.020
Vancouver
Innocenti A, Biban G. Masculinizing chest wall gender-affirming surgery: Clinical outcomes of 73 subcutaneous mastectomies using the double-incision and semicircular incision techniques. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2023. doi:10.1016/j.bjps.2023.07.020
BibTeX
@article{Innocenti2023,
author = {Innocenti, Alessandro and Biban, Gianmarco},
title = {Masculinizing chest wall gender-affirming surgery: Clinical outcomes of 73 subcutaneous mastectomies using the double-incision and semicircular incision techniques},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2023},
doi = {10.1016/j.bjps.2023.07.020}
}
EUVIMED